OpenAI Invests In Coherence Neuro For Brain Cancer Detection
OpenAI and Founders Fund invest in Coherence Neuro, a startup developing brain implants to detect cancer. This investment reflects growing interest in brain data and its potential applications.
Original reporting · wired.com
Original: “OpenAI Invests in Startup That Uses Brain Implants to Detect Cancer”
Read “OpenAI Invests in Startup That Uses Brain Implants to Detect Cancer” at WIRED AI →
How this was written. Diagnosis Forward wrote this article with a language model from WIRED AI’s reporting (model: @cf/meta/llama-3.3-70b-instruct-fp8-fast); it describes that reporting rather than adding to it. The original, linked above, is the full story.
Key points from WIRED AI’s report
- Coherence Neuro has received $45 million in seed funding from OpenAI and Founders Fund to develop a brain implant for cancer detection and treatment.
- The company's technology uses AI models to analyze data from brain implants and identify subtle electrical signals associated with brain tumors.
- OpenAI's investment in Coherence Neuro reflects its growing interest in brain-computer interfaces and their potential applications.
- The company plans to conduct further testing of the implant's recording and stimulation capabilities in a group of patients.
- The ultimate goal of Coherence Neuro is to use the brain implant to detect and treat cancer in real-time, providing a potentially life-saving treatment for patients.
Coherence Neuro, a startup focused on developing brain implants, has received investments from OpenAI's venture capital arm and Peter Thiel's Founders Fund. This investment is part of a $45 million seed funding round, indicating significant interest in the company's technology. The startup's goal is to create a brain implant that can detect and treat cancer, which may lead to new treatments for the disease.
The investment in Coherence Neuro is a notable example of Big Tech's increasing interest in brain data and its potential applications. According to Coherence's CEO, there is a growing synergy between big AI labs and companies building devices to decode the brain. This synergy may lead to significant advancements in the field of brain-computer interfaces.
Coherence Neuro's technology uses AI models to analyze data from brain implants, which can help identify subtle electrical signals associated with brain tumors. The company has already made progress in detecting these signals in animals and is now working to apply this technology to human research. If successful, this technology may revolutionize the way cancer is detected and treated.
OpenAI's investment in Coherence Neuro is not its first foray into brain-computer interfaces. The company has previously invested in Merge Labs, a brain-computer interface company that aims to develop ultrasound technology to decode brain information. This investment suggests that OpenAI is committed to exploring the potential of brain-computer interfaces and their applications.
Coherence Neuro's brain implant is designed not only to detect cancer but also to provide treatment by emitting mild electrical stimulation to halt tumor growth. The company plans to conduct further testing of the implant's recording and stimulation capabilities in a group of patients. This testing will be crucial in determining the safety and efficacy of the implant.
The company's ultimate goal is to use the brain implant to detect and treat cancer in real-time, providing a potentially life-saving treatment for patients. With the new funding, Coherence Neuro aims to launch a clinical trial to test the long-term implantation of the device in patients with glioblastoma, an aggressive type of brain cancer. The success of this trial may pave the way for the development of similar treatments for other types of cancer.
OpenAI's investment in Coherence Neuro is seen as a significant vote of confidence in the company's technology and mission. The partnership between the two companies may lead to further advancements in the field of brain-computer interfaces and cancer treatment. However, it is worth noting that OpenAI will not have access to Coherence Neuro's data, ensuring the privacy and security of patients' health information. This article is based on reporting by WIRED AI.
Questions and answers
What is Coherence Neuro's goal?
Coherence Neuro aims to develop a brain implant that can detect and treat cancer, potentially leading to new treatments for the disease.
Will OpenAI have access to Coherence Neuro's data?
No, OpenAI will not have access to Coherence Neuro's data, ensuring the privacy and security of patients' health information.
What is the next step for Coherence Neuro?
The company plans to conduct further testing of the implant's recording and stimulation capabilities in a group of patients and launch a clinical trial to test the long-term implantation of the device in patients with glioblastoma.
